Primary care can safely manage most people with diabetes when treatment follows the ADA Standards of Care and stays centered on the patient’s actual life, not just the lab report. That means individualized A1c and cardiorenal risk targets, a team that extends beyond one doctor, and clear rules for when a case needs endocrinology. Escalation matters most for complex insulin regimens, recurrent severe hypoglycemia, pregnancy, or a diagnosis that doesn’t fit the usual pattern.
TL;DR:
- Primary care can safely manage most diabetes cases by following ADA standards, focusing on individual risk targets and clear escalation rules for complex situations.
- Building a team that includes DSMES providers, pharmacists, and specialists ensures comprehensive care without requiring full in-house staffing.
- Treatment prioritizes personalized A1c goals, with drug choices like metformin, SGLT2 inhibitors, or GLP-1 agonists based on patient comorbidities and risk profiles.
- Blood pressure and lipid management should be integrated into routine visits, with regular monitoring using A1c, SMBG, or CGM tailored to patient needs.
- Addressing social determinants, cost barriers, and clinic workflow gaps is crucial for preventing therapeutic inertia and ensuring consistent diabetes control.
Table of Contents
- Why Diabetes Management Belongs in Primary Care
- What the ADA Standards of Care Actually Tell Primary Care to Do
- Building a Care Team Around One Physician
- Setting Goals and Choosing Treatment
- Choosing the Right Monitoring Strategy
- Addressing the Barriers That Live Outside the Exam Room
- Running a Clinic That Doesn’t Let Diabetes Slip
- When to Bring in a Specialist
- How This Plays Out in a Busy Clinic
- Getting Diabetes Care Started at Your Family Walk-In Clinic
- Sources
- FAQ
Why Diabetes Management Belongs in Primary Care
Primary care is where diabetes gets diagnosed, treated, and watched over the long haul. Family physicians and nurse practitioners are typically the first clinicians to spot rising glucose on a routine panel, and they’re the ones patients see repeatedly over years, not just during a crisis. That continuity is the whole point: a single A1c tells you where things stand today, but a decade of visits tells you where they’re headed.
Frequent contact also means primary care catches complications before they become emergencies. A foot exam during a routine visit, a quick look at recent labs, a question about vision changes. Small check-ins add up to early intervention, and early intervention is what keeps people out of the hospital.
That doesn’t mean it’s easy. Most clinics run on tight visit slots, and a 15-minute appointment doesn’t leave much room for a full diabetes self-management education and support (DSMES) conversation. Common friction points include:
- Limited visit time to cover glycemic control, blood pressure, lipids, and mental health in one appointment
- Inconsistent access to registered dietitians or certified diabetes educators, especially in smaller practices
- Patients who can’t easily get to specialty referrals for transportation or cost reasons
- Documentation burden that eats into time meant for actual counseling
None of these are reasons to punt diabetes care elsewhere. They’re reasons to build a clinic workflow that compensates, which is exactly what the sections below cover.
What the ADA Standards of Care Actually Tell Primary Care to Do
The Standards of Care in Diabetes, updated every year by the American Diabetes Association, gives primary care an abridged version built specifically for time-constrained visits. The framing is person-centered: glycemic goals, weight, cardiovascular and kidney risk, and social determinants of health all get weighed together instead of chasing A1c in isolation.
The decision cycle the ADA recommends works like this: assess the patient’s health status and preferences, agree on shared goals, choose treatment jointly, then reassess at the next visit and adjust. It’s not a straight line. A patient’s job loss, a new diagnosis of heart failure, or a change in living situation can all shift the plan mid course.
Every recommendation in the Standards also carries an evidence grade, and it’s worth knowing what those letters mean:
- Grade A — clear evidence from well-conducted, generalizable randomized trials
- Grade B — supportive evidence from well-conducted cohort studies
- Grade C — supportive evidence from poorly controlled or uncontrolled studies
- Grade E — expert consensus where trial evidence doesn’t exist or isn’t practical to gather
Pro Tip: When a patient pushes back on a recommendation, checking the evidence grade helps frame the conversation honestly. A Grade A recommendation (like metformin as first-line therapy) is a different conversation than a Grade E one, and patients generally respect that distinction.
For daily practice, the priority list boils down to four things: confirm the diagnosis and classify the type correctly, set an individualized A1c target, screen for complications on a set schedule, and reduce cardiovascular and kidney risk in parallel with glucose control, not after it. Primary care clinicians who treat cardiorenal risk reduction as an afterthought are working from an outdated model of diabetes care.
Building a Care Team Around One Physician
No single clinician manages diabetes alone, even when the physician is the only person the patient regularly sees. The CDC’s overview of diabetes care teams lays out the roles that typically surround a primary care visit: the PCP handles routine checkups, lab orders, and prescriptions, while DSMES specialists, registered dietitians, pharmacists, behavioral health clinicians, podiatrists, and ophthalmologists cover the rest.
Few clinics have all of these under one roof. Here’s a practical way to build the network without hiring a full specialty staff:
- Identify a DSMES program in the area, even a virtual one, and set up a standing referral pathway so it’s a one-click order, not a research project.
- Loop in the pharmacist for medication reconciliation, especially when a patient is on five or more prescriptions.
- Use telehealth for behavioral health. Depression screening is part of routine diabetes care, and virtual counseling access has improved dramatically.
- Schedule annual ophthalmology and podiatry checks as a standing order, not something the patient has to remember to ask about.
- Track outcomes with a simple registry, even a spreadsheet, flagging who’s overdue for A1c, eye exams, or foot checks.
Community health workers and pharmacists can fill a lot of the gap for clinics without in-house dietitians. Evidence on telehealth and team-based care shows it can lower A1c when used alongside, not instead of, in-person visits.
Setting Goals and Choosing Treatment
A1c targets are not one-size-fits-all, and treating them that way is one of the more common mistakes in primary care diabetes management. A healthy 45-year-old with a new diagnosis and no complications might reasonably target an A1c below 7%. An 80-year-old with heart failure, limited life expectancy, and a history of severe hypoglycemia might do better with a target closer to 8% or 8.5%, because the risk of a dangerous low outweighs the marginal benefit of tighter control. Age, comorbidity burden, and hypoglycemia risk should all shape the number before it goes on the chart.
Lifestyle intervention and metformin remain the standard starting point for most people with type 2 diabetes, assuming no contraindication like significant kidney impairment. From there, intensification depends on more than just the A1c trend line. If a patient has established cardiovascular disease, heart failure, or chronic kidney disease, SGLT2 inhibitors and GLP-1 receptor agonists deserve consideration regardless of how close they already are to target, because the outcome trials behind these drug classes show cardiovascular and renal protection independent of glucose lowering.
That said, these are not zero-risk medications. Practical considerations include:
- SGLT2 inhibitors carry a risk of genital yeast infections and, rarely, euglycemic diabetic ketoacidosis; hold before major surgery or prolonged fasting.
- GLP-1 receptor agonists commonly cause nausea, especially during dose escalation, and are contraindicated in patients with a personal or family history of medullary thyroid cancer.
- Both classes require a baseline kidney function check and periodic monitoring afterward.
Insulin becomes necessary when A1c stays well above target despite maximized oral or injectable therapy, or when a patient presents with marked hyperglycemia and symptoms at diagnosis. A simple, primary-care-friendly starting point is basal insulin at a low weight-based dose, titrated every few days based on fasting glucose, with a basal-plus approach (adding a single mealtime rapid-acting dose) if fasting numbers normalize but post-meal readings stay high. For anyone at elevated hypoglycemia risk, glucagon should be prescribed alongside insulin, and patients should know to treat a blood glucose under 70 mg/dL with an appropriate amount of fast-acting glucose.
Blood pressure and lipid management deserve equal billing, not a follow-up conversation. Diabetes accelerates cardiovascular disease, and controlling BP and LDL cholesterol often prevents more downstream harm than the last few tenths of a percentage point on A1c ever will.
Choosing the Right Monitoring Strategy
A1c remains the anchor test, typically checked every three months when a patient is off target or on a new regimen, and every six months once stable at goal. That cadence isn’t arbitrary. A1c reflects roughly the prior three months of average glucose, so testing more often than that measures noise, not progress.
Self-monitored blood glucose (SMBG) and continuous glucose monitoring (CGM) serve different patients. Daily fingersticks for someone on metformin alone rarely change management decisions, and many primary care practices have shifted away from routine SMBG for non-insulin patients, reserving it for symptomatic episodes instead. CGM tells a different story for the right candidate:
- SMBG fits patients on basal insulin who need occasional fasting or pre-meal checks to guide dose titration.
- CGM fits anyone on multiple daily insulin injections, anyone with recurrent hypoglycemia, and increasingly, patients who want more granular feedback on how food and activity affect their glucose.
- Coverage varies by insurer and plan, so verifying benefits before prescribing saves a frustrating call later.
Primary care clinicians deliver most of the ongoing care for type 2 diabetes and should be comfortable reading a basic CGM report even without endocrinology training. The two numbers that matter most on any CGM summary are time in range (the percentage of readings between 70 and 180 mg/dL) and the frequency of lows. A patient with an acceptable A1c but frequent overnight lows on their CGM report needs a dose adjustment, even though the A1c alone would look fine. Understanding same-day A1c testing and how results translate to next steps helps patients stay engaged between visits rather than waiting anxiously for the next appointment.
Addressing the Barriers That Live Outside the Exam Room
A prescription doesn’t help if a patient can’t afford it or doesn’t have a kitchen that supports the diet plan on the handout. The ADA Standards explicitly call for screening social determinants of health as part of routine diabetes care, not as an optional add-on for complicated cases.
A few short questions cover most of the ground: Do you ever run out of food before you can buy more? Do you have reliable transportation to appointments and the pharmacy? Have cost concerns ever made you skip or ration a medication? The answers change the plan.
Cost barriers often have a workaround that doesn’t require a specialist referral:
- Switch to an older, cheaper insulin or generic formulation when clinically appropriate rather than defaulting to the newest agent
- Point patients toward manufacturer patient assistance programs for GLP-1s and SGLT2 inhibitors, which can meaningfully reduce out-of-pocket cost
- Connect food-insecure patients with local food banks or diabetes-friendly meal assistance programs before assuming nonadherence
Shared decision-making means the plan reflects what the patient actually wants from their health, not just what the guideline recommends. A patient who values fewer daily pills over marginally tighter control deserves a plan built around that preference, and that conversation matters as much as the prescription pad.
Running a Clinic That Doesn’t Let Diabetes Slip
Therapeutic inertia, leaving a patient on an unchanged regimen despite an A1c stuck above goal, is one of the most fixable problems in diabetes care, and it’s usually a systems failure, not a clinical judgment failure. A few concrete workflow changes prevent it:
- Set a visit cadence and stick to it: initial evaluation and treatment plan, a follow-up around three months after any medication change, then every three to six months once stable, individualized based on complexity.
- Build a registry that flags anyone with two consecutive above-target A1c readings for proactive outreach rather than waiting for the patient to bring it up.
- Standardize lab order templates so A1c, kidney function, and lipids are automatically bundled at the right intervals instead of ordered piecemeal.
- Pre-fill prior authorization documentation for common agents like GLP-1s so a staff member, not the physician, handles the paperwork chase.
Pro Tip: A standing protocol that automatically triggers a nurse call or portal message when two consecutive A1c readings miss target catches drift months before it becomes a crisis, and it takes the decision out of “did anyone notice” territory.
When to Bring in a Specialist
Most diabetes management belongs in primary care, but a few situations call for endocrinology input, either urgently or on a planned basis. Refer urgently for suspected new-onset type 1 diabetes with ketosis, diabetic ketoacidosis symptoms, or a hyperglycemic crisis. Refer non-urgently for recurrent severe hypoglycemia despite adjustment, pregnancy in a patient with pre-existing diabetes, or an insulin regimen that isn’t responding to standard titration.
A useful referral includes recent A1c trend, current medication list and doses, SMBG or CGM data if available, and current kidney function. Co-management works well for complex cardiorenal cases, where primary care continues routine visits while a specialist manages one specific piece of the plan.
How This Plays Out in a Busy Clinic
Guidelines are one thing; a full waiting room is another. What holds up in practice is same-day A1c testing paired with brief, direct DSMES referrals rather than waiting for a perfect specialty appointment. Clinics that build small, repeatable habits around registries and lab bundling outperform ones chasing every recommendation at once.
— Lisa
Getting Diabetes Care Started at Your Family Walk-In Clinic
Finding a primary care team that treats diabetes as an ongoing partnership, not a once-a-year checkup, makes a real difference in outcomes. Your Family Walk-In Clinic offers same-day A1c testing, routine lab coordination, and primary care appointments seven days a week from 8 AM to 8 PM, so a missed morning at work doesn’t mean waiting weeks for follow-up.
The clinic’s team handles the day-to-day work outlined above: individualized A1c goals, blood pressure and lipid management, medication adjustments, and referrals when a case genuinely needs endocrinology or another specialist. Some situations, like pregnancy with pre-existing diabetes or complex insulin pump management, will still call for specialty coordination, and the clinic is upfront about that rather than trying to handle everything in-house. For patients managing weight alongside glucose control, personalized weight-loss coaching can complement the treatment plan built at each visit.
To get started, book a primary care appointment at Your Family Walk-In Clinic in Lutz, and bring a current medication list along with any recent lab results so the first visit can move straight to a plan.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Sources
- Standards of Care in Diabetes—2025 Abridged for Primary Care
- Your Diabetes Care Team
- Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases
FAQ
Can a primary care physician treat diabetes?
Yes. Primary care physicians manage the large majority of diabetes cases, including diagnosis, medication management, and complication screening, following the ADA Standards of Care, and refer to endocrinology only for complex or unclear cases.
How is newly diagnosed type 2 diabetes managed?
Treatment usually starts with lifestyle changes and metformin, then adds GLP-1 receptor agonists or SGLT2 inhibitors based on A1c response and whether the patient has existing cardiovascular or kidney disease.
What are the 5 M’s of diabetes management?
Definitions of this framework vary across sources, so rather than assert one canonical version, the more reliable approach is to focus on the ADA’s core priorities: glycemic control, weight management, medication selection, monitoring, and cardiorenal risk reduction.
How is type 1 diabetes managed?
Type 1 diabetes requires lifelong insulin therapy, typically through multiple daily injections or an insulin pump, along with regular glucose monitoring via SMBG or CGM and close attention to hypoglycemia prevention. Primary care often co-manages type 1 diabetes alongside endocrinology rather than handling it independently.
When should blood pressure medication start for someone with diabetes?
Most guidelines support starting antihypertensive therapy when blood pressure is elevated in people with diabetes, since blood pressure control reduces cardiovascular and kidney complications as much as glucose control does.
